Health Science Authority
Home

01 Oct 2004:
Withdrawal of rofecoxib (Vioxx®)

HSA advisory on Vioxx®

Please refer to MSD's Dear Healthcare Professional Letter issued on the 1 Oct 2004 announcing the company's independent decision to voluntarily withdraw Vioxx from the worldwide market. More details.


MSD letter to healthcare professional


The Health Sciences Authority (HSA) refers to Merck Sharp & Dohme's (MSD) announcement on its independent decision to voluntarily withdraw Vioxx from the worldwide market. HSA issues an advisory to inform patients of this action and to advise them to consult with a physician about alternative medications. Read the press release.


Last updated on 02 Jul 2010 16:55:56
Best viewed using Internet Explorer 7.0 and above. | Privacy Statement | Terms of Use | HSA Data Protection Policy | Rate Our Website
Health Sciences Authority © 2007-2011. All Rights Reserved.